The unique role of natural killer T cells in the response to microorganisms

Nature Reviews Microbiology

Volumn 5, Issue 6, 2007, Pages 405-417

  Tupin, Emmanuel ^a   Kinjo, Yuki ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD1D ANTIGEN; CYTOKINE; GALACTOSYLDIACYLGLYCEROL; GLYCOLIPID; GLYCOSPHINGOLIPID; LIPOPHOSPHOGLYCAN; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID;

BACTERIAL INFECTION; BACTERIAL MEMBRANE; BORRELIA BURGDORFERI; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MICROORGANISM; MYCOSIS; NATURAL KILLER T CELL; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SALMONELLA; SPHINGOMONAS; SPIROCHETE; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI; VIRUS INFECTION;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; CELL WALL; CYTOKINES; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

NEGIBACTERIA;

EID: 34249103661     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1657     Document Type: Review

References (102)

1. Parekh, V. V., Wilson, M. T. & Van Kaer, L. iNKT-cell responses to glycolipids. Crit. Rev. Immunol. 25, 183-213 (2005).
2. Kronenberg, M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
3. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: What's in a name? Nature Rev. Immunol. 4 231-237 (2004).
4. Brigl, M. & Brenner, M. B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
5. Moody, D. B., Zajonc, D. M. & Wilson, I. A. Anatomy of CD1-lipid antigen complexes. Nature Rev. Immunol. 5, 387-399 (2005).
6. + T cells. Nature 372, 691-694 (1994).
7. Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H. & Koezuka, Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7, 529-534 (1995).
8. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
9. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C. R. & Brenner, M. B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189, 1973-1980 (1999).
10. Sousa, A. O. et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl Acad. Sci. USA 97, 4204-4208 (2000).
11. Sugawara, I. et al. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb) 82, 97-104 (2002).
12. Szalay, G., Zugel, U., Ladel, C. H. & Kaufmann, S. H. Participation of group 2 CD1 molecules in the control of murine tuberculosis. Microbes Infect. 1, 1153-1157 (1999).
13. Dieli, F. et al. An anti-inflammatory role for Vα14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. J. Immunol. 171, 1961-1968 (2003).
14. Kawakami, K. et al. Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol. 46, 207-210 (2002).
15. + T cells for liver injury induced by Salmonella infection in mice. Hepatology 29, 1799-1808 (1999).
16. Joyee, A. G. et al. Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J. Immunol. 178 1048-1058 (2007).
17. Procopio, D. O. et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/ NKT cell pathway. J. Immunol. 169, 3926-3933 (2002).
18. Miyahira, Y. et al. Activation of natural killer T cells by α-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect. Immun. 71, 1234-1241 (2003).
19. Hansen, D. S., Siomos, M. A., Buckingham, L., Scalzo, A. A. & Schofield, L. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18, 391-402 (2003).
20. - subsets of intermediate TCR cells which are constituents of innate immunity. Cell. Immunol. 211, 96-104 (2001).
21. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69, 213-220 (2001).
22. Kawakami, K. et al. Monocyte chemoattractant protein-1-dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167, 6525-6532 (2001).
23. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294-4303 (2002).
24. Exley, M. A. et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69, 713-718 (2001).
25. van Dommelen, S. L., Tabarias, H. A., Smyth, M. J. & Degli-Esposti, M. A. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77, 1877-1884 (2003).
26. Spence, P. M., Sriram, V., Van Kaer, L., Hobbs, J. A. & Brutkiewicz, R. R. Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. Immunology 104, 168-174 (2001).
27. Roberts, T. J., Lin, Y., Spence, P. M., Van Kaer, L. & Brutkiewicz, R. R. CD1d1-dependent control of the magnitude of an acute antiviral immune response. J. Immunol. 172, 3454-3461 (2004).
28. Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
29. Smiley, S. T., Kaplan, M. H. & Grusby, M. J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997).
30. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158, 5112-5119 (1997).
31. Mendiratta, S. K. et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469-477 (1997).
32. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182, 993-1004 (1995).
33. Chiu, Y. H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
34. Skold, M. & Behar, S. M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71, 5447-5455 (2003).
35. Kinjo, Y. & Kronenberg, M. Vα14i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes. J. Clin. Immunol. 25, 522-533 (2005).
36. Yu, K. O. & Porcelli, S. A. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100 42-55 (2005).
37. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33, 3322-3330 (2003).
38. Nieuwenhuis, E. E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Med. 8, 588-593 (2002).
39. Kinjo, T. et al. NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa. Microbes Infect. 8, 2679-2685 (2006).
40. Kumar, H., Belperron, A., Barthold, S. W. & Bockenstedt, L. K. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi J. Immunol. 165, 4797-4801 (2000).
41. McKisic, M. D. & Barthold, S. W. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect. Immun. 68, 5190-5197 (2000).
42. Amprey, J. L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904 (2004).
43. + vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12, 1267-1274 (2000).
44. Mattner, J., Donhauser, N., Werner-Felmayer, G. & Bogdan, C. NKT cells mediate organ-specific resistance against Leishmania major infection. Microbes Infect. 8, 354-362 (2006).
45. Duthie, M. S., Kahn, M., White, M., Kapur, R. P. & Kahn, S. J. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1drestricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73, 181-192 (2005).
46. Grubor-Bauk, B., Simmons, A., Mayrhofer, G. & Speck, P. G. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J. Immunol. 170, 1430-1434 (2003).
47. Cornish, A. L. et al. NKT cells are not critical for HSV-1 disease resolution. Immunol. Cell Biol. 84, 13-19 (2006).
48. Ashkar, A. A. & Rosenthal, K. L. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77, 10168-10171 (2003).
49. Lin, Y., Roberts, T. J., Spence, P. M. & Brutkiewicz, R. R. Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J. Leukoc. Biol. 77, 151-158 (2005).
50. Renukaradhya, G. J. et al. Virus-induced inhibition of CD1d1-mediated antigen presentation: Reciprocal regulation by p38 and ERK. J. Immunol. 175, 4301-4308 (2005).
51. Sanchez, D. J., Gumperz, J. E. & Ganem, D. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115 1369-1378 (2005).
52. Yuan, W., Dasgupta, A. & Cresswell, P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nature Immunol. 7, 835-842 (2006).
53. Hage, C. A. et al. Human immunodeficiency virus gp120 downregulates CD1d cell surface expression. Immunol. Lett. 98 131-135 (2005).
54. Chen, N. et al. HIV-1 down-regulates the expression of CD1d via Nef. Eur. J. Immunol. 36, 278-286 (2006).
55. Levy, O. et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 188, 948-953 (2003).
56. Pasquier, B. et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201, 695-701 (2005).
57. Nichols, K. E. et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Med. (2005).
58. Rigaud, S. et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444, 110-114 (2006).
59. Bilenki, L. et al. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J. Immunol. 175, 3197-3206 (2005).
60. Nakano, Y. et al. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages. Microbes Infect. 4, 1-11 (2002).
61. Ronet, C. et al. NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J. Immunol. 175, 899-908 (2005).
62. Szalay, G. et al. Cutting edge: Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-β 2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 162, 6955-6958 (1999).
63. Smiley, S. T. et al. Exacerbated susceptibility to infection-stimulated immunopathology in CD1ddeficient mice. J. Immunol. 174, 7904-7911 (2005).
64. Arrunategui-Correa, V. & Kim, H. S. The role of CD1d in the immune response against Listeria infection. Cell. Immunol. 227, 109-120 (2004).
65. + NKT cells participate in the early response to enteric Listeria monocytogenes infection. J. Immunol. 175, 1137-1144 (2005).
66. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. & Brenner, M. B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nature Immunol. 4, 1230-1237 (2003).
67. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
68. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
69. De Libero, G. et al. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22, 763-772 (2005).
70. Berntman, E., Rolf, J., Johansson, C., Anderson, P. & Cardell, S. L. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur. J. Immunol. 35, 2100-2109 (2005).
71. Skold, M., Xiong, X., Illarionov, P. A., Besra, G. S. & Behar, S. M. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J. Immunol. 175, 3584-3593 (2005).
72. Raghuraman, G., Geng, Y. & Wang, C. R. IFN-β-mediated up-regulation of CD1d in bacteria-infected APCs. J. Immunol. 177, 7841-7848 (2006).
73. Faveeuw, C. et al. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J. Immunol. 169, 906-912 (2002).
74. Mallevaey, T. et al. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J. Immunol. 176, 2476-2485 (2006).
75. Kronenberg, M. & Gapin, L. Natural killer T cells: Know thyself. Proc. Natl Acad. Sci. USA 104, 5713-5714 (2007).
76. Nagarajan, N. A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706-2713 (2007).
77. Montoya, C. J. et al. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J. Immunol. 177, 1028-1039 (2006).
78. Schofield, L. et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283, 225-229 (1999).
79. Molano, A. et al. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 164, 5005-5009 (2000).
80. Romero, J. F., Eberl, G., MacDonald, H. R. & Corradin, G. CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice. Parasite Immunol. 23, 267-269 (2001).
81. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA 101, 10685-10690 (2004).
82. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunol. 7, 978-986 (2006).
83. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
84. Sriram, V., Du, W., Gervay-Hague, J. & Brutkiewicz, R. R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35, 1692-701 (2005)
85. Neef, A., Witzenberger, R. & Kampfer, P. Detection of sphingomonads and in situ identification in activated sludge using 16S rRNA-targeted oligonucleotide probes. J. Ind. Microbiol. Biotechnol. 23, 261-267 (1999).
86. Kawahara, K., Moll, H., Knirel, Y. A., Seydel, U. & Zahringer, U. Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. Eur. J. Biochem. 267, 1837-1846 (2000).
87. Kawahara, K., Kubota, M., Sato, N., Tsuge, K. & Seto, Y. Occurrence of an α-galacturonosyl-ceramide in the dioxin-degrading bacterium Sphingomonas wittichii. FEMS Microbiol. Lett. 214, 289-294 (2002).
88. Hsueh, P. R. et al. Nosocomial infections caused by Sphingomonas paucimobilis: Clinical features and microbiological characteristics. Clin. Infect. Dis. 26, 676-681 (1998).
89. Perola, O. et al. Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial waterborne epidemic among neutropenic patients. J. Hosp. Infect. 50, 196-201 (2002).
90. Orloski, K. A., Hayes, E. B., Campbell, G. L. & Dennis, D. T. Surveillance for Lyme disease - United States, 1992-1998. MMWR CDC Surveill. Summ. 49, 1-11 (2000).
91. Ben-Menachem, G., Kubler-Kielb, J., Coxon, B., Yergey, A. & Schneerson, R. A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 100, 7913-7918 (2003).
92. + natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
93. Tupin, E. et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199, 417-422 (2004).
94. Nakai, Y. et al. Natural killer T cells accelerate atherogenesis in mice. Blood 104, 2051-2059 (2004).
95. Brossay, L. et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528 (1998).
96. Matsuda, J. L. & Gapin, L. Developmental program of mouse Vα14i NKT cells. Curr. Opin. Immunol. 17, 122-130 (2005).
97. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
98. Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
99. + T cells. Annu. Rev. Immunol. 12, 635-673 (1994).
100. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 (2006).
101. Wu, D. et al. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc. Natl Acad. Sci. USA 103, 3972-3977 (2006).
102. De Libero, G., Macdonald, H. R. & Dellabona, P. T cell recognition of lipids: Quo vadis? Nature Immunol. 8, 223-227 (2007).